Abstract
Because there is an unexpected action of testosterone (T) to increase follicle-stimulating hormone (FSH) production in the absence of gonadotropin-releasing hormone (GnRH) in the rat, the effects of T treatment on circulating FSH were studied in men with GnRH deficiency. FSH immunoreactivity was identified in serum using a sensitive two-site immunoassay in each of five untreated GnRH-deficient men. Analysis by gel filtration chromatography revealed that circulating immunoreactive FSH coeluted with radiolabeled authentic FSH. T enanthate treatment suppressed serum FSH levels in each subject from (mean +/- standard error of the mean [SEM]) 1.02 +/- 0.94 to 0.26 +/- 0.21 mIU/ml (P = 0.061, Wilcoxon rank sum test). Thus, FSH is produced in GnRH-deficient men, but there is no evidence for the stimulatory effect of T on FSH production in the absence of GnRH, as observed in the rat. These preliminary data provide further evidence that male contraceptive strategies using GnRH antagonists to suppress LH and FSH production in normal men will not be counteracted by T replacement therapy, although the issue deserves further attention in that study population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
